A new treatment may be on the horizon for people with a major form of inflammatory bowel disease (IBD) called Crohn's disease, after a McMaster University-led study identified serotonin as a possible trigger of flare-ups. ...
Nov 9, 2021
0
134
Alcohol and cannabis sales in Canada have been higher during the COVID-19 pandemic compared to pre-pandemic sales. Since March 2020, monthly alcohol sales increased by an average of 5.5 percent over expected sales, while ...
Nov 4, 2021
0
20
New research from McMaster University has found that a simple tweak in the tones used by medical devices can significantly lower annoyance caused by these alarms, improving hospital working environments and even patient care.
Oct 14, 2021
0
32
Patients using take-home technology following non-elective surgery resulted in significantly greater detection and correction of drug errors, and reduction in patients' pain, says a national study led by Hamilton researchers.
Sep 30, 2021
0
2
A major study has found that convalescent plasma does not reduce the risk of intubation or death for COVID-19 patients. However, the study also revealed that the antibody profile in the blood of people who have had the virus ...
Sep 9, 2021
0
209
A one-day online therapy session can help treat postpartum depression (PPD), says a study led by McMaster University scientists.
Sep 8, 2021
0
11
A combination therapy of aspirin, statins and at least two blood pressure medications given in fixed doses can slash the risk of fatal cardiovascular disease (CVD) by more than half, says an international study led by Hamilton ...
Aug 29, 2021
3
554
A commonly-used pesticide could be partially responsible for the global obesity epidemic, says a study led by McMaster University scientists.
Aug 27, 2021
1
1235
Dawn Bowdish and Andrew Costa, researchers with Canada's Global Nexus for Pandemics and Biological Threats, have shared important initial findings from an unpublished study on COVID-19 immunity responses in Ontario long-term ...
Aug 19, 2021
0
2
An inexpensive oral antidepressant can save the lives of COVID-19 patients and cut hospital admissions by up to 30 percent, says a study co-led by McMaster University.
Aug 19, 2021
0
649
